While our study provides valuable insights into the differential metabolic adaptations in insulin-treated (GDM-I) and diet-managed (GDM-D) pregnancies, a larger cohort with more diverse demographic and clinical characteristics would help validate these findings. This evidence concerns the gene INS and gestational diabetes.